Core Scientific (CORZ) Cash from Investing Activities (2021 - 2026)

Core Scientific has reported Cash from Investing Activities for 6 years, with the latest figure at -$796.2 million in Q2 2026.

• Quarterly Cash from Investing Activities fell 565.71% year-over-year to -$796.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.7 billion (down 538.35% YoY) and the FY2025 annual result came in at -$740.8 million, down 678.16% from the prior year.
• Cash from Investing Activities slipped to -$796.2 million in Q2 2026 per CORZ's latest filing, from -$386.7 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $2.4 million in Q4 2023 and troughed at -$796.2 million in Q2 2026.
• A 5-year average of -$145.1 million and a median of -$60.5 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities jumped 101.69% in 2023, then plunged 3656.53% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$139.5 million in 2022, then surged by 101.69% to $2.4 million in 2023, then tumbled by 1320.25% to -$28.8 million in 2024, then tumbled by 864.54% to -$277.8 million in 2025, then plunged by 186.66% to -$796.2 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$796.2 million, -$386.7 million, and -$277.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.